Prulifloxacin: in vitro (HERG current) and in vivo (conscious dog) assessment of cardiac risk

This publication has 8 references indexed in Scilit:

• In Vitro Antibacterial Activities of AF 3013, the Active Metabolite of Prulifloxacin, against Nosocomial and Community Italian Isolates
  Antimicrobial Agents and Chemotherapy, 2001
• Interactions of a Series of Fluoroquinolone Antibacterial Drugs with the Human Cardiac K⁺Channel HERG
  Molecular Pharmacology, 2001
• Effects of fluoroquinolones on HERG currents
  European Journal of Pharmacology, 2000
• Sparfloxacin but not levofloxacin or ofloxacin prolongs cardiac repolarization in rabbit Purkinje fibers
  Fundamental & Clinical Pharmacology, 1998
• Efficient gene transfer to dispersed human pancreatic islet cells in vitro using adenovirus-polylysine/DNA complexes or polycationic liposomes
  Diabetes, 1996
• Pharmacokinetics and Safety of NM441, a New Quinolone, in Healthy Male Volunteers
  The Journal of Clinical Pharmacology, 1994
• In vitro antibacterial activity of a new quinolone, NM394
  Antimicrobial Agents and Chemotherapy, 1991
• Improved patch-clamp techniques for high-resolution current recording from cells and cell-free membrane patches
  Pflügers Archiv - European Journal of Physiology, 1981